Mainstay Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-26,140
| Closed | -$633K | – | 104 |
|
|
2022
Q1 | $633K | Buy |
26,140
+183
| +0.7% | +$4.43K | 0.12% | 69 |
|
|
2021
Q4 | $606K | Sell |
25,957
-6,073
| -19% | -$142K | 0.18% | 76 |
|
|
2021
Q3 | $532K | Buy |
32,030
+4,665
| +17% | +$77.5K | 0.3% | 67 |
|
|
2021
Q2 | $667K | Sell |
27,365
-200
| -0.7% | -$4.88K | 0.16% | 77 |
|
|
2021
Q1 | $711K | Sell |
27,565
-1,990
| -7% | -$51.3K | 0.22% | 76 |
|
|
2020
Q4 | $1.58M | Sell |
29,555
-145
| -0.5% | -$7.75K | 0.46% | 35 |
|
|
2020
Q3 | $1.23M | Sell |
29,700
-3,270
| -10% | -$135K | 0.32% | 47 |
|
|
2020
Q2 | $1.6M | Buy |
32,970
+160
| +0.5% | +$7.76K | 0.47% | 32 |
|
|
2020
Q1 | $1.33M | Sell |
32,810
-945
| -3% | -$38.2K | 0.43% | 28 |
|
|
2019
Q4 | $1.44M | Buy |
+33,755
| New | +$1.44M | 0.33% | 52 |
|